Clinical Trial Update: Spironolactone for the Treatment of Melasma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating spironolactone for the treatment of melasma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melasma

Drugs mentioned

• Spironolactone (spironolactone)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Melasma | Phase 1 | Status: WITHDRAWN